Study objectives Primary assessment of mediastinal lymph nodes (N2 or N3) for staging
lung cancer by transthoracic needle with or without core biopsy. Mediastinoscopy only …

Purpose: To correlate FDG activity on PET with the expression of glucose transporter
proteins Glut-1 and Glut-3 in patients with early stage non-small cell lung cancer (NSCLC) …

Image-guided transthoracic, bronchoscopic, and endoscopic ultrasound fine needle
aspiration (FNA) greatly facilitates lung cancer staging by having the potential to precisely …

PURPOSE Tc-99m depreotide is a peptide analogue of a somatostatin receptor that
preferentially binds to somatostatin receptors 2, 3, and 5. Many lung tumors may express …

Paraneoplastic syndromes may be the presenting clinical manifestation of small cell lung
cancer. In some cases, however, confirming the diagnosis can be difficult because findings …

The novel technique of single-exposure, dual-energy digital chest radiography appears
promising for the detection of pulmonary nodules and lung cancers. In a preliminary study …

Positron emission tomography (PET) constitutes a major advance in the diagnosis, staging,
prognostic assessment, and follow-up of lung cancer. However, it is not a magic bullet that …

Positron emission tomography (PET) with F-18 fluorodeoxyglucose (FDG) is an important
tool in differentiating benign from malignant lesions [1]. Patients with increased FDG uptake …

La tipificación de la lesión orgánica subyacente a una determinada sintomatología clínica
es el primer paso en la elección de la estrategia terapéutica más adecuada. En el caso de …

Lung cancer is the leading cause of cancer-related deaths in the United States. Filling a gap
in the literature, this resource translates recent laboratory findings into practical applications …